Silver Point Capital

PatientPoint has been the leader and innovator of patient and physician engagement solutions at the point of care. PatientPoint award-winning health information drives meaningful outcomes for patients, providers and sponsors. From primary care to specialty practices, from urgent care clinics to hospitals, PatientPoint programs provide an integrated patient-engagement experience across care settings. PatientPoint specializes in point-of-care education by custom-making content to meet the unique needs of patients in the physician’s office or hospital. This content has been recognized for the last 12 years by the National Health Information Awards for excellence in consumer-facing health information. This seal of quality helps healthcare professionals recognize exemplary patient education that is easy-to-understand, visually compelling and actionable.

Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.

Imperium Renewables, Inc., together with its subsidiary, produces and markets biodiesel in the United States. The company produces biodiesel from feedstock oils; and glycerin, a by-product of biodiesel. Its biodiesel is used as alternative fuel in cars, trucks, ships, trains, and planes. The company markets its products through a network of distributors. Imperium Renewables, Inc. was formerly known as Seattle Biodiesel, LLC and changed its name to Imperium Renewables, Inc. in May 2005. The company was founded in 2004 and is based in Seattle, Washington. It has production facilities in Hoquiam, Washington; and Oahu, Hawaii.